Skip to main content
Premium Trial:

Request an Annual Quote

Takeda Partners with Sanford-Burnham on Heart Failure Research

NEW YORK (GenomeWeb) – Takeda Pharmaceutical today announced it has signed a partnership with Sanford-Burnham Medical Research Institute to study the role of gene regulatory proteins as targets for the treatment of heart failure.

The partners will screen and develop molecules that may improve the metabolism and function of a damaged heart. Sanford-Burnham and Takeda scientists will collaborate to validate the targets and molecules with a goal of creating new treatments for heart failure.

New molecules to treat heart failure represent "a critical unmet medical need," Tetsuyuki Maruyama, head of Takeda pharmaceutical research, said in a statement.

In patients suffering from cardiovascular disease, the heart tissue loses its metabolic activity, becoming energy-starved. The aim of the partnership is to identify a molecule that could reactivate the heart, the partners said in a statement.

Takeda and Sanford-Burnham said that researchers will work with Sanford-Burnham's Conrad Prebys Center for Chemical Genomics to screen the institute’s library of compounds to find potentially effective molecules.

Financial and other terms of the agreement were not disclosed.

This is the third research collaboration between Takeda and Sanford-Burnham in the last five years, the partners said. In 2010, the two partnered to find biomarkers for obesity-related treatments.

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.